Hold at $519.80: Reject Buy on extended setup; 1.5% cap with Overweight-ready posture pending pullback or confirmed breakout
The aggressive analyst's structural thesis (13.4% five-year CAGR, $373B cash earning 5%+, Q2 2026 operating earnings strength, 13% operating earnings CAGR, buyback reactivation under Abel) is genuinely compelling and is precisely why the Hold rating carries an Overweight-ready posture. However, the pattern database across 12 iterations has demonstrated that this specific setup — resistance overhead at $529.42, RSI elevated at 67.28, forward P/E stretched at 23.42x, price above upper Bollinger Band $517.97 in a hawkish Fed regime — consistently produces modest Hold alpha (+0.6% to +1.3%) and has not produced breakout alpha on any prior Buy attempt. The disciplined path is to let the breakout confirm before escalating, while maintaining high-quality exposure via the 1.5% cap and Overweight-ready execution framework. The aggressive thesis gets fully monetized when price confirms it; it gets destroyed when chasing resistance with concentrated tech beta exposure.
| Position | Action |
|---|---|
| At or above $509-$520 (upper Bollinger Band + triple-tested resistance) | Reject Tranche 1 entry; no-add zone |
| $504-508 (50 SMA/10 EMA confluence) | Scaled adds: $508 (30%), $504 (30%), $500-502 (40%) |
| $470-480 on 200 SMA break and hold | Deep add zone for regime-change confirmation |
| Close >$529.42 on volume >5M with MACD histogram expanding toward +0.30+ | Escalate to Overweight; deploy at $529.42, $535-540, $545-550 |
| $520-525 with volume below 20-day average AND BRK-B underperforming SPY/XLF | Trim 10-15% |
| Strict 1.5% portfolio cap | No exceptions; maintain current weight |
Berkshire Hathaway is a quality compounder trading at a value multiple with macro tailwinds from Fed rate hikes, an active $4B+ quarterly buyback program signaling insider conviction, and a 35% undervaluation thesis—presenting a rare intersection of growth, value, and capital return.
| Indicator | Value | Signal |
|---|---|---|
| Close | $519.80 | neutral |
| 10 EMA | $511.51 | bullish |
| 50 SMA | $504.51 | bullish |
| 200 SMA | $492.63 | bullish |
| RSI (14) | 67.28 | neutral |
| MACD | +2.83 | bullish |
| MACD Signal | +1.36 | bullish |
| MACD Histogram | +1.47 | bullish |
| Bollinger Upper Band | $517.97 | neutral |
| Bollinger Middle Band | $506.09 | neutral |
| Bollinger Lower Band | $494.21 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Technical indicators show healthy momentum, not euphoric exhaustion
↩ rebuts: “Technicals are overbought and a pullback is imminent”
EV: +35% (Simply Wall St. undervaluation thesis) · concedes: 5-10% correction possible on Red October macro, but would likely only bring stock to $467-495 range still inside the structural uptrend; AI concentration could see 5-15% drawdown in that 31% sleeve, but this would be a buying opportunity rather than thesis break; Recession could cause earnings dip, though Berkshire has historically outperformed in recessions
BRK-B at $519.80 is a late-cycle entry near 52-week highs with deteriorating macro, overbought technicals, triple-tested overhead resistance, and a forward P/E that suggests analysts expect ~44% earnings decline — not a quality compounder at value multiples.
EV: -2.4% · concedes: The balance sheet is too strong, the cash position too defensive, and the operating model too resilient for a short thesis; AXP revenue outlook upgrade is positive; The $300B+ cash position does provide some defensive cushion in a risk-off environment; Berkshire's annual FCF generation of $20-25B is substantial
→ vs conservative: Treating Fed hawkishness as a headwind is backwards — $300B+ cash earning elevated short rates, expanding insurance float, and short-duration bond portfolio are structural tailwinds in this regime
→ vs conservative: RSI at 67.28 is not overbought — momentum indicators stay elevated in trending markets, and prior August peak had RSI at 74
→ vs neutral: Forward P/E of 23.42 versus TTM 13.06 is optical distortion from investment gains; operating earnings stable at $10-11B per quarter regardless of mark-to-market noise
→ vs conservative: Red October 20% correction scenario is buying opportunity — Berkshire buybacks accelerate during drawdowns and management will step in with the checkbook
→ vs conservative: AI concentration at 31% is not vulnerability but Abel's aggressive capital deployment signal with Buffett's backing; tech upside with value-stock volatility is asymmetric
→ vs neutral: Entry at $519.80 above upper Bollinger band at $517.97 is not chasing — volume at 5.25M shows accumulation, and compressed ATR signals trend expansion ahead
| neutral |
| ATR (14) | $6.15 | neutral |
| VWMA (20) | $507.71 | bullish |
| Key Resistance | $529.42 | neutral |
| Key Support | $504.51 | neutral |
Support: 511.51 · 504.51 · 494.21 · 492.63 | Resistance: 523.74 · 529.42 · 535 · 540
BRK-B exhibits strong bullish technical structure with all three moving averages in proper ascending order and price trading $27.17 above the 200 SMA at $492.63. Momentum is firmly bullish with MACD having crossed above zero on September 2 and histogram expanding for nine consecutive sessions, while RSI at 67.28 remains below but near the 70 overbought threshold. The August 21 low of $495.82 established a higher low versus the March and April lows (~$467 and $464.01 respectively), confirming structural accumulation. Volatility has contracted 28% from the August peak ATR of $8.53 down to $6.15, suggesting an orderly recovery rather than euphoric advance. The report rates the stock HOLD with bullish bias, recommending additions on pullbacks to $511–$515 (10 EMA zone) with stops below $502, and identifying a confirmed daily close above $529.42 on volume exceeding 5M shares as a potential upgrade to BUY.
Market Cap
$1.113 trillion
52-Week High
$537.74
52-Week Low
$464.01
50-Day Average
$504.20
200-Day Average
$492.58
Beta
0.603
TTM P/E
13.06
Forward P/E
23.42
EPS (TTM)
$39.79
Book Value (per share)
$522,225.90
Revenue (TTM)
$384.7B
Net Income
$85.8B
Operating Margin
32.56%
Profit Margin
22.30%
ROE
12.12%
ROA
6.01%
Total Assets
$1.263 trillion
Stockholders' Equity
$747.9B
Total Debt
$128.6B
Net Debt
$88.0B
Cash + ST Investments
$365.5B
Equity Investments
$323.78B
Current Ratio
2.89
Free Cash Flow (TTM)
$71.98B
Quarterly OCF
$11.22B
Quarterly FCF
$5.57B
Buybacks
$4.21B
CapEx
$5.65B
Net Investment Purchases
$18.26B
Revenue Growth
+19.2%
Net Income Growth
+106.8%
Debt/Equity
17.14
Strengths
Concerns
Berkshire Hathaway trades at a significant discount to the S&P 500 with a TTM P/E of 13.06 and near 1.5x book value, supported by record quarterly revenue of $117.89B and doubled YoY net income growth despite $16B in unrealized investment losses. The resumption of aggressive buybacks ($4.21B in Q2 2026) and $18.3B in net investment purchases represent strong insider signals of undervaluation, though forward earnings consensus suggests normalization ahead.
Macro: Fed turned decisively hawkish on 2026-09-16: rate hike delivered (Dow –600 pts), Polymarket pricing 95% probability of zero Fed cuts in 2026, US recession odds rising at 12% (+4pp WoW), 10-Year Treasury below 5% but rising into the decision. Berkshire is structurally well-positioned for this hiking cycle (cash/float earning high short rates, insurance float income accreting, low bond duration) but faces equity beta drag from 31% concentration in two AI mega-cap tech names.